tetradecanoylphorbol acetate has been researched along with Diabetic Angiopathies in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (66.67) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caimi, G; Canino, B; Ferrara, F; Lo Presti, R; Montana, M; Musso, M; Porretto, F | 1 |
| Drábiková, K; Holománová, D; Jancinová, V; Murín, J; Nosál', R; Solík, P | 1 |
| Birch, KA; Dell, C; Heath, WF; Hermeling, RN; Johnston, CM; Reifel-Miller, A; Smith, C; Stramm, L; Williamson, JR | 1 |
| De Michele, T; De Sole, P; Di Salvo, S; Giardina, B; Pennacchietti, L; Zappacosta, B | 1 |
| Dietz, R; Haller, H; Heintze, U; Hempel, A; Lindschau, C; Luft, FC; Maasch, C | 1 |
| Chaushev, TA; Dakovska, LN; Ivanov, GI; Kyurkchiev, SD | 1 |
| Dimmeler, S; Eriksson, P; Hamsten, A; Henney, A; Jormsjö, S; Moritz, J; Walter, DH; Ye, S; Zeiher, AM | 1 |
| Banga, JD; De Groot, PG; Nievelstein, PF; Ottenhof-Rovers, M; Sixma, JJ; Wynne, HJ | 1 |
| Chang, K; Easom, RA; Sherman, WR; Turk, J; Williamson, JR; Wolf, BA | 1 |
1 trial(s) available for tetradecanoylphorbol acetate and Diabetic Angiopathies
| Article | Year |
|---|---|
On the antioxidant activity of carvedilol in human polymorphonuclear leukocytes in vitro and ex vivo.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Antioxidants; Carbazoles; Carvedilol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Heart Failure; Humans; In Vitro Techniques; Luminescence; Luminol; Male; Middle Aged; Neutrophils; Propanolamines; Reactive Oxygen Species; Tetradecanoylphorbol Acetate | 2006 |
8 other study(ies) available for tetradecanoylphorbol acetate and Diabetic Angiopathies
| Article | Year |
|---|---|
Polymorphonuclear leukocyte integrin pattern, at baseline and after activation, in type 2 diabetic subjects with macrovascular complications.
Topics: Aged; CD11a Antigen; CD11b Antigen; CD11c Antigen; CD18 Antigens; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Integrins; Male; Middle Aged; Neutrophils; Tetradecanoylphorbol Acetate | 2003 |
LY290181, an inhibitor of diabetes-induced vascular dysfunction, blocks protein kinase C-stimulated transcriptional activation through inhibition of transcription factor binding to a phorbol response element.
Topics: Animals; Base Sequence; Capillaries; Cattle; Cells, Cultured; Chloramphenicol O-Acetyltransferase; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelium, Vascular; Enzyme Inhibitors; Fibroblasts; Humans; Male; Molecular Sequence Data; Naphthalenes; Oligodeoxyribonucleotides; Phorbol 12,13-Dibutyrate; Promoter Regions, Genetic; Protein Kinase C; Pyrans; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Retinal Vessels; Skin; Tetradecanoylphorbol Acetate; Transcription Factors; Transcriptional Activation; Urokinase-Type Plasminogen Activator | 1996 |
Resting and stimulated human polymorphonuclear leucocytes from type-2 diabetic patients: change in purine nucleotide pattern.
Topics: Adenine Nucleotides; Adult; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Guanine Nucleotides; Humans; In Vitro Techniques; Inflammation; Male; Middle Aged; Neutrophils; Purine Nucleotides; Respiratory Burst; Tetradecanoylphorbol Acetate | 1997 |
High glucose concentrations increase endothelial cell permeability via activation of protein kinase C alpha.
Topics: Animals; Base Sequence; Cell Membrane Permeability; Cells, Cultured; Diabetic Angiopathies; Endothelium, Vascular; Enzyme Activation; Glucose; Humans; Immunohistochemistry; Isoenzymes; Oligonucleotide Probes; Protein Kinase C; Protein Kinase C-alpha; Protein Kinase C-epsilon; Swine; Tetradecanoylphorbol Acetate | 1997 |
Increased adhesion of lymphoid cells to glycated proteins.
Topics: Animals; Cattle; Cell Adhesion; Diabetes Mellitus; Diabetic Angiopathies; Glycation End Products, Advanced; Glycoproteins; Humans; Jurkat Cells; Lymphocytes; Monocytes; Receptor for Advanced Glycation End Products; Receptors, Immunologic; T-Lymphocytes; Tetradecanoylphorbol Acetate; U937 Cells | 1999 |
Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease.
Topics: Adult; Alleles; Angioplasty, Balloon, Coronary; Animals; Cells, Cultured; Coronary Angiography; Coronary Disease; Diabetic Angiopathies; Gene Expression Regulation, Enzymologic; Humans; Insulin; Male; Matrix Metalloproteinase 12; Metalloendopeptidases; Mice; Middle Aged; Polymorphism, Genetic; Promoter Regions, Genetic; Stents; Tetradecanoylphorbol Acetate; Transcription Factor AP-1 | 2000 |
Platelet adhesion and aggregate formation in type I diabetes under flow conditions.
Topics: Adult; Aged; Blood Platelets; Cell Communication; Cells, Cultured; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Endothelium, Vascular; Extracellular Matrix; Female; Heparin; Humans; Incidence; Male; Middle Aged; Platelet Adhesiveness; Platelet Aggregation; Tetradecanoylphorbol Acetate | 1991 |
Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels.
Topics: Alkaloids; Animals; Capillary Permeability; Diabetic Angiopathies; Diglycerides; Glucose; Glycerides; Granulation Tissue; Male; Microcirculation; NAD; Protein Kinase C; Rats; Rats, Inbred Strains; Staurosporine; Tetradecanoylphorbol Acetate | 1991 |